Boston Scientific Corporation (NYSE: BSX) is beginning to market the CRI Amigo™ system, a remote-controlled catheter system, and related accessories in select European countries through an exclusive agreement with Catheter Robotics, Inc. (CRI). The CRI Amigo™ system, CE marked in 2010 and compatible with certain Boston Scientific and other commercially available catheters, lets physicians remotely manoeuvre diagnostic and ablation catheters designed to treat common cardiac arrhythmias during electrophysiology procedures. Boston Scientific plans to market the Amigo system in Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Portugal, Spain and Switzerland.
“To perform successful ablation procedures, electrophysiologists require precise control over catheter tip placement,” said Jean Paul Albenque, M.D., Clinique Pasteur, Toulouse, France. “The Amigo Remote Catheter System, used in combination with the predictable steering and stability of Boston Scientific’s leading RF ablation catheters, offers improved comfort and reduced radiation exposure without sacrificing performance.”
“The Amigo Remote Catheter System, used in combination with the predictable steering and stability of Boston Scientific’s leading RF ablation catheters, offers improved comfort and reduced radiation exposure without sacrificing performance.”
The Amigo system is designed to integrate easily into existing catheter labs for use in simple and complex procedures to diagnose and treat cardiac arrhythmias. It connects to the handle of specific electrophysiological catheters and lets the physician remotely operate the catheter with a controller. The system is intended to allow full operation of all catheter functions while reducing a physician’s radiation exposure during the procedure.
The Amigo system is compatible with Boston Scientific’s Blazer™ and Blazer™ Open-Irrigated radiofrequency (RF) ablation catheters and Chilli II® fluid cooled RF ablation catheter. The Blazer Open-Irrigated Catheter, which launched in CE Mark countries in May 2011, is an advanced catheter that integrates Total Tip Cooling™ Design, which is intended to consistently cool the entire tip electrode during RF energy delivery.
“The Amigo system complements our leading line of EP catheters, offering electrophysiologists an intuitive solution for remote operation while retaining the full functionality of their preferred ablation catheter platforms,” said Michael Onuscheck, Executive Vice President and President of Boston Scientific EMEA. “This agreement with Catheter Robotics is an important step in our continued focus on advancing cardiac ablation solutions for European physicians and their patients.”
Affecting more than 4.5 million Europeans, atrial fibrillation is an arrhythmia associated with a rapid rhythm in the upper chambers of the heart. Patients are most often treated with anti-arrhythmic drugs, which can often cause adverse side effects. Cardiac ablation with an RF ablation catheter is increasingly becoming an option for patients who cannot tolerate these medications.
In the U.S., the Blazer Open-Irrigated Catheter is an investigational device, limited by applicable law to investigational use only and not available for sale.
Source: Boston Scientific